Since 1992 we have stood by more than 45.000 patients in Greece suffering from OSA, COPD and other respiratory disorders, becoming one of the biggest and oldest companies in the field of respiratory devices. 1993 was an important year for our company due to the beginning of distribution of ResMed products which became the global leader manufacturer in the treatment of sleep apnea (such as CPAP devices and masks). Sleep apnea can have a dramatic effect on patient’s daytime function but mostly can cause all of the common vascular diseases such as hypertension, heart attack or stroke. It is remarkable that 40 years since the invention of the continuous positive airway pressure (CPAP), it is still the front-line therapy for OSA. But now what matters most, is that when experienced well trained experts manage the OSA patient at the beginning, then the compliance with CPAP treatment can be excellent.
We are one of the biggest and oldest companies in Greece in the field of respiratory devices
© 2024 Raftopoulos. All rights reserved.